Quantum-Si incorporated operates the first next-generation protein sequencing platform for the healthcare industries.
| Revenue (TTM) | $1.85M |
| Gross Profit (TTM) | 741,000 |
| EBITDA | $-91.23M |
| Operating Margin | -9323.00% |
| Return on Equity | -46.40% |
| Return on Assets | -24.80% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $0.92 |
| Price-to-Book | 1.14 |
| Price-to-Sales (TTM) | 124.64 |
| EV/Revenue | 56.71 |
| EV/EBITDA | 0.63 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -69.40% |
| Shares Outstanding | $197.82M |
| Float | $179.33M |
| % Insiders | 10.51% |
| % Institutions | 29.95% |
Volatility is currently contracting